Boston Business Journal: Gene Therapy Regulation News, Life Science Media, Back Bay in the NewsStephen Gauldie, PhDAugust 22, 2019Drug Regulation
Back Bay in Boston Business Journal: Biogen Crisis News, Back Bay in the NewsBack Bay Life Science AdvisorsAugust 2, 2019Media, Boston Ecosystem
Global Data: Antibiotic Sales News, Back Bay in the NewsBack Bay Life Science AdvisorsApril 9, 2019Antiobiotic Sales, BioPharm Insight
Xconomy: Gossamer Bio Turns Back from Alternative IPO Path News, Back Bay in the Newsjonathan gertlerFebruary 4, 2019Biotech, IPO
Boston Business Journal: Reverberations of the Shutdown Felt by MA Businesses News, Back Bay in the NewsBack Bay Life Science AdvisorsJanuary 23, 2019BioPharma Development, Boston Life Science Ecosystem
Back Bay in STAT: Antibiotic Breakthroughs News, Peter Bak Posts, Back Bay in the NewsBack Bay Life Science AdvisorsDecember 10, 2018Antibiotics, Anti-microbials, Drug development
Med Device Online: Examining Medtech's Booming Heart Valve Market News, Back Bay in the NewsBack Bay Life Science AdvisorsAugust 22, 2018Heart Valve, MedDevice, Medical Device Manufacturers
Xconomy: Proxima Aims to Fill CRO Gap for Houston’s Growing Biotech Community Jonathan Gertler Posts, News, Back Bay in the Newsjonathan gertlerMarch 14, 2018Biotech, healthcare, Jonathan Gertler, Wall Street Journal, WSJ
Back Bay in the Boston Globe: Health Care Execs Could Lift GE’s Efforts in Life Sciences Back Bay in the NewsBack Bay Life Science AdvisorsJune 13, 2017Boston Globe, GE Healthcare, Jonathan Gertler
Back Bay in US News and World Report: Biggest Financial Headlines of 2016 Jonathan Gertler Posts, News, Back Bay in the NewsBack Bay Life Science AdvisorsJanuary 3, 2017Investment Banking, Biotech Financing
Scrip Intelligence: Early-Stage Funding Slips Again (VC Roundup) Back Bay in the News, NewsBack Bay Life Science AdvisorsDecember 9, 2016VC, Investment Banking, Biotech Funding
Back Bay in the Boston Globe: Crispr IPO Doesn't Hit It's Target News, Back Bay in the NewsBack Bay Life Science AdvisorsOctober 24, 2016Gene Editing, IPO, Investment Banking
Wall Street Journal Pro Equity: Healthcare Tech Trends News, Back Bay in the NewsBack Bay Life Science AdvisorsSeptember 20, 2016Healthtech
Xconomy: Many Biotechs Need Inside IPO Help, But Selecta Is An Extreme Case News, Back Bay in the NewsBack Bay Life Science AdvisorsJune 22, 2016Biotech IPO
